Safety and efficacy from a 6 ‐week double‐blind study and a 52‐week open‐label extension of aripiprazole in adolescents with schizophrenia in Japan

Psychiatry and Clinical Neurosciences,Volume 0, Issue ja, -Not available-.

Source: Psychiatry and Clinical Neurosciences - May 18, 2018 Category: Neuroscience Authors: Hideo Matsumoto MD, PhD , Jun Ishigooka MD, PhD , Hiroaki Ono BSc , Yoshihiro Tadori PhD Source Type: research